Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation.

Wojciech G LesniakSrikanth BoinapallyGabriela LoflandZirui JiangCatherine A FossBabak Behman AzadAnna JablonskaMauro A GarciaMaria BrzezinskiMartin G Pomper

Published in: International journal of nanomedicine (2024)

tumors. This approach holds promise for enhancing image-guided treatment of aggressive, metastatic subtypes of prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
small cell lung cancer
squamous cell carcinoma
cancer therapy
computed tomography
machine learning
drug delivery
combination therapy
pain management
mesenchymal stem cells
chronic pain
artificial intelligence